Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) saw a large decrease in short interest in December. As of December 30th, there was short interest totalling 28,700 shares, a decrease of 24.1% from the December 15th total of 37,800 shares. Based on an average trading volume of 32,200 shares, the days-to-cover ratio is presently 0.9 days.
Alpha Tau Medical Trading Up 8.5 %
Alpha Tau Medical stock traded up $0.03 during midday trading on Friday, hitting $0.43. The stock had a trading volume of 12,588 shares, compared to its average volume of 32,317. The firm's fifty day moving average is $0.29 and its two-hundred day moving average is $0.43. Alpha Tau Medical has a 52-week low of $0.18 and a 52-week high of $1.06.
Get
Alpha Tau Medical alerts:
Institutional Investors Weigh In On Alpha Tau Medical
Several hedge funds and other institutional investors have recently added to or reduced their stakes in DRTSW. Goldman Sachs Group Inc. purchased a new stake in Alpha Tau Medical in the 1st quarter worth approximately $42,000. Chicago Partners Investment Group LLC bought a new position in Alpha Tau Medical in the 1st quarter worth approximately $55,000. Jane Street Group LLC bought a new position in Alpha Tau Medical in the 1st quarter worth approximately $64,000. Whitebox Advisors LLC bought a new position in Alpha Tau Medical in the 3rd quarter worth approximately $65,000. Finally, Walleye Trading LLC bought a new position in Alpha Tau Medical in the 1st quarter worth approximately $65,000.
About Alpha Tau Medical
(Get Rating)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.
See Also
- Get a free copy of the StockNews.com research report on Alpha Tau Medical (DRTSW)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
阿尔法头医疗有限公司(纳斯达克代码:DRTSW-GET Rating)看到空头股数在12月份大幅下降。截至12月30日,空头股数共有28,700股,比12月15日的37,800股减少了24.1%。以32,200股的平均成交量计算,目前天数与回补比率为0.9天。
Alpha Tau医疗交易上涨8.5%
Alpha Tau Medical的股票在周五午盘交易中上涨0.03美元,触及0.43美元。该股成交量为12,588股,而其平均成交量为32,317股。该公司的50日移动均线切入位为0.29美元,200日移动均线切入位为0.43美元。Alpha Tau Medical的52周低点为0.18美元,52周高点为1.06美元。
到达
Alpha Tau医疗公司警报:
机构投资者看好Alpha Tau Medical
几家对冲基金和其他机构投资者最近增持或减持了DRTSW的股份。高盛股份有限公司在第一季度购买了阿尔法头医疗公司价值约42,000美元的新股份。芝加哥合作伙伴投资集团有限责任公司在第一季度购买了Alpha Tau Medical的一个新头寸,价值约5.5万美元。简街集团有限责任公司在第一季度购买了阿尔法头医疗公司的一个新头寸,价值约64,000美元。Whitebox Advisors LLC在第三季度购买了Alpha Tau Medical的一个新头寸,价值约65,000美元。最后,Walleye Trading LLC在第一季度购买了Alpha Tau Medical的一个新头寸,价值约6.5万美元。
关于Alpha Tau Medical
(获取评级)
Alpha Tau医疗有限公司是一家临床阶段的肿瘤治疗公司,在以色列和美国从事用于治疗实体癌症的扩散阿尔法放射疗法(Alpha DART)的研究、开发和商业化。其Alpha-DART技术用于皮肤癌、口腔癌、胰腺癌和乳腺癌的临床试验,以及肝细胞癌、肺癌和前列腺癌的临床前研究。
另请参阅
- 免费获取StockNews.com关于Alpha Tau Medical(DRTSW)的研究报告
- 市场回顾周-1/16-1/20
- Old Dominion是否表明Trucking正在踩刹车?
- 诺德斯特龙对零售业降价的担忧
- 埃克森美孚股票:在Buy Point附近
- 高股息率的必和必拓认为中国推动了23年的增长
获得Alpha Tau医学日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Alpha Tau Medical和相关公司的最新新闻和分析师评级的每日简要摘要。